Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - CASH FROM OPERATIONS
Cash from Operations ANVS - Annovis Bio, Inc.
-40 M
LAST VALUE
-109.20%
2 YEAR CAGR
-134.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR